HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Very low and high predialysis serum bicarbonate levels are risk factors for mortality: what are the Appropriate Interventions?

Abstract
Adjustment of bath [HCO(3)(-)] to "normalize" predialysis serum [HCO(3)(-)] in patients receiving intermittent hemodialysis has been advocated to prevent the adverse effects of metabolic acidosis. However, when mortality risk has been evaluated in hemodialysis patients in relation to their nadir serum [HCO(3)(-)], an increase in risk is noted both with very low values (<18 mmol/l) and very high values (>27 mmol/l). If mortality risk is adjusted for comorbidity, age and effectiveness of dialysis, as well as for nutritional and inflammatory factors, very low predialysis values remain an independent risk factor, but the risk for high values virtually disappears. Patients with mild predialysis metabolic acidosis (serum [HCO(3)(-)] 18-23 mmol/l) have the lowest mortality risk. Metabolic acidosis has adverse effects on bone and muscle metabolism in patients receiving hemodialysis but, unless the acidosis is severe, these effects appear to be overshadowed by nutritional and inflammatory influences. This commentary reviews the principles of acid-base homeostasis in patients receiving intermittent hemodialysis and the studies that have addressed the adverse effects of metabolic acidosis in this patient population. It concludes that high predialysis serum [HCO(3)(-)] values are likely a marker for malnutrition and comorbidity, whereas very low values may be an indication for direct treatment. The latter should be addressed using strategies to increase predialysis values, whereas the former need attention directed to nutritional factors and comorbidity.
AuthorsF John Gennari
JournalSeminars in dialysis (Semin Dial) 2010 May-Jun Vol. 23 Issue 3 Pg. 253-7 ISSN: 1525-139X [Electronic] United States
PMID20636916 (Publication Type: Journal Article, Review)
Chemical References
  • Bicarbonates
Topics
  • Bicarbonates (blood)
  • Decision Making
  • Humans
  • Kidney Failure, Chronic (blood, mortality, therapy)
  • Renal Dialysis
  • Risk Factors
  • Survival Rate (trends)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: